Skip to main content
. 2016 Aug 25;7(40):65614–65626. doi: 10.18632/oncotarget.11592

Table 3. Fungal and micro-algal strains used in this study and their source.

Taxonomic position Strain Source
Fungi Cryptococcus neoformans H99 Heitman1 (clinical strain)
Cryptococcus neoformans CAP59 De Cock2 (laboratory strain)
Cryptococcus neoformans 201 Nawrot3 (clinical strain)
Cryptococcus neoformans AM/08 Dyląg4 (clinical strain)
Cryptococcus neoformans No.8 Dyląg4 (clinical strain)
Cryptococcus gattii R265 May5 (clinical strain)
Cryptococcus uniguttulatus MD1 Dyląg4 (environmental strain)
Exophiala dermatitidis MD1 Dyląg4 (clinical strain)
Algae Prototheca zopfii Jagielski6 (clinical strain)
Prototheca wickerhamii Jagielski6 (clinical strain)
Prototheca blaschkeae Jagielski6 (clinical strain)
Prototheca zopfii var. hydrocarbonea Jagielski6 (clinical strain)
1

Joseph Heitman – Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, USA

2

Hans de Cock – Department of Biology, Microbiology, Institute of Biomembranes, Utrecht University, Utrecht, The Netherlands

3

Urszula Nawrot – Department of Microbiology, Wroclaw Medical University, Chalubinskiego Street 4, Wroclaw, Poland

4

Mariusz Dyląg – Department of Genetics, Institute of Genetics and Microbiology, University of Wroclaw, Przybyszewskiego Street 63/77, Wroclaw, Poland

5

Robin May – School of Biosciences and Institute of Microbiology & Infection, University of Birmingham, Edgbaston, Birmingham, United Kingdom

6

Tomasz Jagielski – Department of Applied Microbiology, Institute of Microbiology, University of Warsaw, Miecznikowa 1 Street, Warsaw, Poland